Molecule Name |
DB11602
|
DrugBank Groups |
Approved
|
Cluster No |
335
|
Smiles |
O2(C(OC1(C(OCC(O)C)C(OCC(O)C)C(OCC(O)C)OC1COCC(O)C))C(OCC(O)C)C(OCC(O)C)C(C2COCC(O)C)OCC(O)C)
|
Download |
mol2, pdbqt
|
TPSA |
263,37
|
Non-H Atoms |
55
|
Non-C/H Atoms |
19
|
Metal-Atoms |
0
|
Electronegative Atoms |
19
|
Stereo Centers |
18
|
Rotatable Bonds |
28
|
Rings Closures |
2
|
Small Rings |
2
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
55
|
Symmetric atoms |
0
|
cLogS |
-1,841
|
MW |
806,933
|
cLogP |
-2,3235
|
HBA |
19
|
HBD |
8
|
Ro5 violations |
3
|
Druglikeness |
-7,1815
|
DrugScore |
0,120490655200444
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
high
|
Irritant |
low
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,4028
|
Caco-2 Permeability 2 |
0,4249
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
2,3311
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,4382
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,178
|
Carcinogenicity (Three-class) |
Non-required
|